Your browser is no longer supported. Please, upgrade your browser.
Settings
INSY INSYS Therapeutics, Inc. daily Stock Chart
INSY [NASD]
INSYS Therapeutics, Inc.
Index- P/E23.02 EPS (ttm)0.66 Insider Own0.20% Shs Outstand70.70M Perf Week-5.07%
Market Cap1.07B Forward P/E17.40 EPS next Y0.87 Insider Trans3.60% Shs Float22.82M Perf Month-3.01%
Income49.90M PEG0.82 EPS next Q0.09 Inst Own49.80% Short Float69.26% Perf Quarter-4.95%
Sales311.50M P/S3.44 EPS this Y49.20% Inst Trans-7.37% Short Ratio19.98 Perf Half Y-13.22%
Book/sh3.62 P/B4.19 EPS next Y120.20% ROA15.00% Target Price25.40 Perf Year-54.38%
Cash/sh2.24 P/C6.77 EPS next 5Y28.00% ROE20.00% 52W Range11.45 - 37.19 Perf YTD-47.01%
Dividend- P/FCF15.89 EPS past 5Y28.50% ROI22.80% 52W High-59.72% Beta1.93
Dividend %- Quick Ratio2.90 Sales past 5Y- Gross Margin91.90% 52W Low30.83% ATR0.99
Employees510 Current Ratio3.30 Sales Q/Q-13.50% Oper. Margin24.20% RSI (14)41.08 Volatility7.99% 6.37%
OptionableYes Debt/Eq0.00 EPS Q/Q-39.30% Profit Margin16.00% Rel Volume1.32 Prev Close15.17
ShortableYes LT Debt/Eq0.00 EarningsAug 03 BMO Payout0.00% Avg Volume791.06K Price14.98
Recom1.80 SMA20-11.94% SMA50-2.64% SMA200-20.22% Volume131,477 Change-1.25%
Apr-12-16Reiterated Jefferies Buy $23 → $17
Apr-11-16Reiterated Piper Jaffray Overweight $46 → $28
Feb-24-16Reiterated Jefferies Buy $36 → $23
Feb-01-16Reiterated RBC Capital Mkts Outperform $49 → $44
Mar-09-15Reiterated RBC Capital Mkts Outperform $65 → $71
Mar-04-15Reiterated RBC Capital Mkts Outperform $57 → $65
Dec-15-14Reiterated RBC Capital Mkts Outperform $53 → $57
Nov-12-14Reiterated RBC Capital Mkts Outperform $51 → $53
Nov-12-14Downgrade Oppenheimer Outperform → Perform $40
Oct-02-14Initiated RBC Capital Mkts Outperform $51
Aug-14-13Reiterated Oppenheimer Outperform $23 → $27
Jul-31-13Initiated Oppenheimer Outperform $23
Aug-26-16 08:13AM  INSYS Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : INSY-US : August 26, 2016
Aug-25-16 12:31PM  Illinois attorney general sues Insys over fentanyl drug marketing Reuters
Aug-24-16 12:48PM  Biotech gains amid buyout chatter, upbeat clinical trial results at CNBC
12:02PM  ETFs with exposure to INSYS Therapeutics, Inc. : August 24, 2016
06:50AM  Insys Therapeutics Reports Phase 3 Trial of Sublingual Buprenorphine Spray Met Primary Endpoint in Patients with Moderate-to-Severe Postoperative Pain after Bunionectomy GlobeNewswire
Aug-23-16 09:06AM  2 Big Back-Alley Brawls Break Out in Washington Over Policy at Motley Fool
Aug-21-16 08:02PM  Harvard Explains The Health Effects Of Medical And Recreational Use Of Marijuana
Aug-19-16 05:32PM  Insys Therapeutics Starts Enrollment in Cannabidiol Trial
Aug-18-16 06:50AM  Insys Therapeutics Announces First Patient Enrolled in Phase II Trial for the Treatment of Cocaine Dependence Using Pharmaceutical Cannabidiol GlobeNewswire
Aug-17-16 05:28PM  Ex-Insys employees plead not guilty in U.S. drug-kickback case Reuters -7.09%
Aug-16-16 01:04PM  INSYS THERAPEUTICS, INC. Financials
Aug-13-16 03:18PM  Did the DEA Just Give These Marijuana Companies a Big Break? at Motley Fool
Aug-11-16 11:45AM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
09:15AM  DEA Expected To Reject Rescheduling Of Marijuana, Expand Cultivation For Research at Forbes
08:20AM  Why Jefferies Sees 3 Big Biotechs Having Key Upside Catalysts Coming at 24/7 Wall St.
Aug-10-16 08:30AM  Identifying Newest Cannabis Strains for Cancer Treatment and Other Ailments Gain Headway Behind Pharmacological Evaluations CNW Group
Aug-08-16 02:16PM  ETFs with exposure to INSYS Therapeutics, Inc. : August 8, 2016
Aug-05-16 03:14PM  INSYS THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report
11:04AM  INSYS Therapeutics, Inc. :INSY-US: Earnings Analysis: Q2, 2016 By the Numbers : August 5, 2016
Aug-04-16 04:11PM  INSYS Therapeutics, Inc.: Gathering momentum, can it sustain its performance?
Aug-03-16 02:57PM  Edited Transcript of INSY earnings conference call or presentation 3-Aug-16 2:00pm GMT +17.43%
09:02AM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
07:07AM  Q2 2016 INSYS Therapeutics Inc Earnings Release - Before Market Open
07:02AM  Insys Therapeutics tops 2Q profit forecasts
06:50AM  Insys Therapeutics Reports Second Quarter 2016 Results GlobeNewswire
Aug-02-16 08:35AM  Medical Product Stocks Earnings Preview for Aug 3: BIO, CSII & More
Aug-01-16 11:35AM  These 5 Stocks Are Set to Soar on Bullish Earnings
Jul-26-16 04:24PM  Investors Are Betting Big Against Insys Therapeutics -- Here's Why You Shouldn't at Motley Fool
09:00AM  Six Major Biotech Acquisitions You Could See In 2016 (Part 3) at Forbes
Jul-22-16 04:38PM  The Marijuana Industry Is Growing Like Weeds
10:07AM  Huge Drugmaker Fines for Bribing Healthcare Providers at Motley Fool
Jul-20-16 04:30PM  Insys Therapeutics to Report Second Quarter 2016 Results GlobeNewswire
04:20PM  This Marijuana Drugmaker Sets Its Sights on a 9-Figure Market at Motley Fool
Jul-19-16 09:04AM  How Do Healthcare Companies Market Their Products? at Motley Fool
Jul-18-16 08:30AM  Pharmaceutical Studies & Trials of Individual Cannabinoids Aim to Develop Cannabis Strains That Specifically Target Cancer Pain and Nausea CNW Group
Jul-08-16 09:15AM  Recent Market Movers - Eleven Biotherapeutics Insys Therapeutics Himax Technologies and Broadcom
Jul-06-16 09:20AM  Coverage of Top Gainers Leading Brands Himax Technologies and Insys Therapeutics
08:07AM  INSYS Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : INSY-US : July 6, 2016
Jul-05-16 06:32PM  Goldman Sachs, Halliburton and Delta fall; Clorox climbs +6.90%
05:07PM  Why Insys Therapeutics, Endeavour Silver, and Himax Technologies Jumped Today at Motley Fool
04:21PM  Insys Stock Jumps As FDA Approves Appetite-Boosting Cannabis Drug
03:42PM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
03:04PM  FDA Approves Insys Therapeutics' 2nd Cannabis-Based Drug at Forbes
02:52PM  What's Got This Marijuana Stock Jumping Double-Digits Today at Motley Fool
02:45PM  Insys Therapeutics (INSY) Stock Soars on FDA Approval
01:55PM  Biotech Movers: Insys Therapeutics Inc (INSY) and Cempra Inc (CEMP) at Insider Monkey
09:16AM  Insys's stock soars after cannabis-based oral drug gets FDA approval at MarketWatch
08:40AM  Insys Soars on Huge FDA Win at 24/7 Wall St.
08:12AM  Insys Therapeutics: FDA Approves Treatment for AIDS Symptoms at The Wall Street Journal
06:55AM  Insys Therapeutics Announces FDA Approval of Syndros GlobeNewswire
06:43AM  Top Bets of Parametrica Management Barrons Penta No. 1 Fund at Insider Monkey
Jul-01-16 09:00AM  Zeldes Haeggquist & Eck, LLP Announces Investigation of INSYS Therapeutics, Inc. Business Wire
Jun-27-16 04:11PM  GW Pharma Jumps As Cannabis Drug Treats Severe Epilepsy -9.19%
Jun-21-16 09:00AM  Buy Insys Therapeutics Before Medical Marijuana Reaches A Tipping Point at Forbes
Jun-20-16 05:22PM  Which Stocks To Watch Ahead Of The Potential Us-Wide Federal Legalization Of Medical Cannabis
Jun-13-16 08:19AM  INSYS Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : INSY-US : June 13, 2016
Jun-10-16 03:28PM  Former Insys employees charged in doctor kickback scheme at CNBC -12.73%
Jun-03-16 07:16PM  Weeding Out the Winners in Race for Cannabis-Based Drugs -7.24%
May-28-16 03:11PM  How Hedge Funds Traded Marijuana Stocks in Q1 at Insider Monkey
May-26-16 04:30PM  Insys Therapeutics, Inc. to Present at Two Upcoming Conferences in June GlobeNewswire
08:20AM  INSYS Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : INSY-US : May 26, 2016
May-24-16 09:00PM  This Marijuana Stock Takes a Step Forward at Motley Fool +6.07%
06:50AM  Insys Therapeutics Successfully Completes Safety and Pharmacokinetic (PK) Study of Cannabidiol Oral Solution in Pediatric Epilepsy Patients GlobeNewswire
May-18-16 03:40PM  4 Top Stocks in the Growing Medical Marijuana Industry
09:26AM  4 Best Stocks in the Thriving Medical Marijuana Industry at TheStreet
May-16-16 04:00PM  Repros Announces the Appointment of Mr. Patrick Fourteau as Chairman of the Board GlobeNewswire
May-13-16 03:43PM  What You Need To Know About Investing In Marijuana Stocks at Motley Fool
May-10-16 02:22PM  Here's Why Insys Therapeutics Inc. Fell 14.3% in April at Motley Fool
May-09-16 06:04PM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submiss
May-05-16 06:11AM  INSYS THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report
May-02-16 01:14PM  INSYS Therapeutics, Inc. :INSY-US: Earnings Analysis: Q1, 2016 By the Numbers
Apr-28-16 03:05PM  Edited Transcript of INSY earnings conference call or presentation 28-Apr-16 2:00pm GMT
10:36AM  Insys Therapeutics beats Street 1Q forecasts AP
09:02AM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online
07:07AM  Q1 2016 INSYS Therapeutics Inc Earnings Release - Before Market Open CCBN
06:50AM  Insys Therapeutics Reports First Quarter 2016 Results GlobeNewswire
Apr-26-16 04:30PM  Insys Therapeutics, Inc. to Present at Deutsche Bank 41st Annual Health Care Conference GlobeNewswire
Apr-25-16 01:45PM  5 Earnings Stocks Everyone Hates but You Should Love at TheStreet
Apr-18-16 10:20AM  Biotech and Pharmaceuticals Highlight Jefferies Top Growth Stock Buys at 24/7 Wall St. +5.03%
Apr-15-16 05:59PM  What Falling Estimates & Price Mean for INSYS Therapeutics (INSY)
11:48AM  These 3 Marijuana-Related Stocks Are Poised for Strong Growth at TheStreet
Apr-14-16 04:30PM  Insys Therapeutics to Report First Quarter 2016 Results GlobeNewswire
Apr-13-16 07:00PM  Cramer: These stocks hit me like a snake bite at CNBC
02:02PM  Roddy Boyd Nailed Insys Therapeutics Thesis
07:49AM  Markets Fall on Earnings Worry: Biotech Stocks Follow Suit
12:47AM  [$$] Pharma Guidance Is Bad, Timing Is Worse at The Wall Street Journal
Apr-12-16 12:49PM  [$$] Pharma Guidance Is Bad, Timing Is Worse at The Wall Street Journal
11:25AM  Endo Pharmaceuticals: The Most Attractive Valeant-Like Company? at Barrons.com
Apr-11-16 05:02PM  Stocks Reverse Lower; Alcoa Earnings Top Views -19.37%
03:56PM  What Has Insys Theraepeutics Shares Crashing 20% Today at Motley Fool
03:37PM  Insys Therapeutics (INSY) Stock Tanks on Preliminary Subsys Revenues at TheStreet
01:11PM  Endo International Tumbles as Insys Expects Weak Painkiller Sales at TheStreet
12:06PM  Why These 5 Stocks Are Trending Ahead of Earnings Season Kickoff at Insider Monkey
09:05AM  Insys Therapeutics Sinks on Missed Revenue Estimates at 24/7 Wall St.
09:04AM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
06:50AM  Insys Therapeutics Reports Preliminary Estimated Revenues from Subsys for the First Quarter 2016 GlobeNewswire
Apr-06-16 12:43PM  The truth about Denver, revealed by a 25-year-old Denver native +10.18%
08:19AM  INSYS Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : INSY-US : April 6, 2016
Apr-01-16 04:44PM  Scott + Scott, LLP Reminds Investors of April 4, 2016 Deadline to File Lead Plaintiff Papers in Insys Therapeutics (INSY) Securities Case GlobeNewswire +5.69%
03:30PM  UPCOMING DEADLINE: Levi & Korsinsky, LLP Notifies Shareholders of INSYS Therapeutics, Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of April 4, 2016 INSY GlobeNewswire
Insys Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes supportive care products. The company markets Subsys, a sublingual fentanyl spray for breakthrough cancer pain in opioid-tolerant cancer patients in the United States. Its lead product candidate is Syndros, an orally administered liquid formulation of dronabinol. The company is also developing Cannabidiol Oral Solution, a synthetic cannabidiol for childhood catastrophic epilepsy syndromes; and other product candidates, including other dronabinol line extensions and sublingual spray product candidates. Insys Therapeutics, Inc. is headquartered in Chandler, Arizona.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
STANLEY THEODORE HDirectorAug 16Option Exercise5.9615,00089,40017,000Aug 16 08:23 PM
STANLEY THEODORE HDirectorAug 16Sale18.0215,000270,3002,000Aug 16 08:23 PM
JOHN N KAPOOR TRUST DATED SEPT10% OwnerAug 12Buy18.575,700105,85342,430,310Aug 12 03:40 PM
FOURTEAU PATRICKDirectorAug 11Sale18.4615,000276,90049,682Aug 12 04:51 PM
BRENNAN DANIELExec VP & Chf Operations Off.Aug 09Sale19.165,781110,7521Aug 09 07:12 PM
MEYER STEVEN JDirectorAug 04Option Exercise14.081,19416,80633,583Aug 04 06:49 PM
MEYER STEVEN JDirectorJul 06Option Exercise14.4469510,03632,389Jul 06 04:12 PM
MEYER STEVEN JDirectorJun 07Option Exercise14.081,19416,80631,694Jun 07 09:33 PM
BAKER DARRYL SChief Financial OfficerMay 23Option Exercise13.5710,000135,70021,030May 23 04:40 PM
MEYER STEVEN JDirectorMay 18Option Exercise13.575006,78530,500May 18 04:39 PM
JOHN N KAPOOR TRUST DATED SEPT10% OwnerMay 12Buy12.4110,000124,11942,424,610May 12 07:06 PM
JOHN N KAPOOR TRUST DATED SEPT10% OwnerMay 11Buy12.9440,000517,70842,414,610May 12 07:06 PM
MEYER STEVEN JDirectorApr 14Option Exercise4.8712,00058,47030,000Apr 14 06:54 PM
FOURTEAU PATRICKDirectorMar 04Sale18.2215,000273,30064,682Mar 04 04:52 PM
MEYER STEVEN JDirectorFeb 05Option Exercise8.3218,000149,83018,000Feb 09 02:12 PM
FOURTEAU PATRICKDirectorNov 12Sale26.4830,000794,40079,682Nov 13 03:38 PM
JOHN N KAPOOR TRUST DATED SEPT10% OwnerNov 11Buy25.5210,000255,22142,359,610Nov 13 03:25 PM
Babich Michael LPresident and CEOSep 22Option Exercise1.6216,06826,030421,572Sep 22 06:36 PM
STANLEY THEODORE HDirectorSep 14Option Exercise3.632,0007,2604,000Sep 14 05:24 PM
STANLEY THEODORE HDirectorSep 14Sale38.082,00076,1602,000Sep 14 05:24 PM
STANLEY THEODORE HDirectorSep 10Option Exercise3.632,0007,2604,000Sep 14 05:24 PM
STANLEY THEODORE HDirectorSep 10Sale36.002,00072,0072,000Sep 14 05:24 PM